SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-481067
Filing Date
2013-12-20
Accepted
2013-12-20 16:30:59
Documents
5
Period of Report
2013-12-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d637489d8k.htm 8-K 43631
2 EX-10.1 d637489dex101.htm EX-10.1 71860
3 EX-10.2 d637489dex102.htm EX-10.2 64514
4 EX-10.3 d637489dex103.htm EX-10.3 64621
5 EX-10.4 d637489dex104.htm EX-10.4 64357
  Complete submission text file 0001193125-13-481067.txt   310267
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 131291913
SIC: 2836 Biological Products, (No Diagnostic Substances)